James Adams

James practices in Corporate Law advising clients in relation to negotiated private equity transactions, cross-border mergers and acquisitions, joint ventures and corporate reorganisations. James has extensive experience in advising private equity and venture capital investors on complex equity structures involving multiple share classes.

• Advised CataCap on  its USD 145 million acquisition of the AerFin group from CarVal Investors (including in connection with the management incentive programme)
• Advised Post Holdings, Inc on its USD 1.8 billion acquisition of Weetabix from Bright Food Group and Baring Private Equity Asia
• Advised The Rohatyn Group on its EUR 40 million investment in the Amethyst Radiotherapy group
• Advised Core Equity on the acquisition of Portman Dental from Livingbridge and management
• Advised Platinum Equity LLC on disposal of Worldwide Flight Services group to Cerberus Capital Management for EUR 1.2 billion
• Advised the management team of the DMC group in connection with the management incentive arrangements on a sale by Bluegem Capital Partners to Lion Capital
• Advised the management team of the Lawyers on Demand on a sale to Bowmark Capital LLP
• Advised a group of private equity investors on disposal of Amoun Pharmaceutical (an Egyptian generics pharmaceuticals company) to Valeant for c. USD 800 million
• Advised Jones Lang Lasalle in connection with the USD 330 million purchase of Integral UK Ltd
• Advised Montagu Private Equity and Ares in respect of the management incentive arrangements for Euromedic
• Advised the management team of Global Blue on the tertiary buy-out by Silverlake and Partners Group from Equistone Private Equity for EUR 1 billion
• Advised the management team of Ideal Standard (a Bain portfolio company) on a restructuring of their management equity scheme, one of the first restructurings seeing management participating in the senior and mezzanine debt performance